Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
These can help with sleep apnea
Phase 3 data from the ATTAIN-1 trial, which evaluated 3,127 adults with obesity over 72 weeks, showed a mean weight loss of 11.2%, with more than half of participants achieving at least 10% body weight reduction
For employers, the rise of GLP-1 medications as a treatment option for obesity and their significant cost has focused attention on the potential of these medications to manage cardiometabolic conditions as well
A newer GLP-1 receptor agonist, tirzepatide, demonstrates weight loss as high as 20% change in body weight compared with 3% in the placebo group in a RCT
If a brand drug isnt covered, youll find an available generic equivalent
US$ 27.75
US$ 28.22
US$ 22.34
